CR9635A - Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente - Google Patents
Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondienteInfo
- Publication number
- CR9635A CR9635A CR9635A CR9635A CR9635A CR 9635 A CR9635 A CR 9635A CR 9635 A CR9635 A CR 9635A CR 9635 A CR9635 A CR 9635A CR 9635 A CR9635 A CR 9635A
- Authority
- CR
- Costa Rica
- Prior art keywords
- therapeutic antibody
- diana
- ancient
- absence
- independently
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 6
- 238000001514 detection method Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05014618 | 2005-07-06 | ||
| EP06004447 | 2006-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9635A true CR9635A (es) | 2008-02-20 |
Family
ID=36922121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9635A CR9635A (es) | 2005-07-06 | 2007-12-21 | Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070009976A1 (https=) |
| EP (2) | EP1902315A1 (https=) |
| JP (1) | JP2008545145A (https=) |
| KR (1) | KR20080016939A (https=) |
| AR (1) | AR053948A1 (https=) |
| AU (1) | AU2006265275A1 (https=) |
| BR (1) | BRPI0612591A2 (https=) |
| CA (1) | CA2613187A1 (https=) |
| CR (1) | CR9635A (https=) |
| EC (1) | ECSP088081A (https=) |
| IL (1) | IL188317A0 (https=) |
| MA (1) | MA29730B1 (https=) |
| MX (1) | MX2008000277A (https=) |
| MY (1) | MY157955A (https=) |
| NO (1) | NO20076662L (https=) |
| NZ (1) | NZ564471A (https=) |
| RU (1) | RU2008103608A (https=) |
| TW (1) | TWI312864B (https=) |
| WO (1) | WO2007003420A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130056201A (ko) * | 2000-05-19 | 2013-05-29 | 제넨테크, 인크. | ＥｒｂＢ 길항제에 의한 암 치료요법에 대한 효과적인 반응의 가능성을 개선시키기 위한 유전자 검출 분석 |
| KR20140032004A (ko) | 2004-07-22 | 2014-03-13 | 제넨테크, 인크. | Ｈｅｒ２ 항체 조성물 |
| KR101134208B1 (ko) | 2004-10-01 | 2012-04-09 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 촬상 장치 및 그 방법 |
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| EP1850874B1 (en) | 2005-02-23 | 2013-10-16 | Genentech, Inc. | Extending time to disease progression or survival in ovarian cancer patients using pertuzumab |
| PE20070207A1 (es) * | 2005-07-22 | 2007-03-09 | Genentech Inc | Tratamiento combinado de los tumores que expresan el her |
| US8358354B2 (en) | 2009-01-26 | 2013-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical abberations |
| US8243157B2 (en) | 2006-02-07 | 2012-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical aberrations |
| MX2009008981A (es) | 2007-03-02 | 2009-09-02 | Genentech Inc | Prediccion de respuesta a un inhibidor her. |
| TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物 |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| WO2013055874A2 (en) | 2011-10-14 | 2013-04-18 | Genentech, Inc. | Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| KR101327542B1 (ko) * | 2012-03-15 | 2013-11-08 | 광주과학기술원 | 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법 |
| AU2012232949B2 (en) * | 2012-09-28 | 2014-07-03 | Willowtree Holdings Pty Ltd | Temporary bulkhead |
| RU2019115089A (ru) | 2013-04-16 | 2019-06-11 | Дженентек, Инк. | Варианты пертузумаба и их аналитическая характеристика |
| JP2017513901A (ja) | 2014-04-25 | 2017-06-01 | ジェネンテック， インコーポレイテッド | トラスツズマブ−ｍｃｃ−ｄｍ１及びペルツズマブにより早期の乳癌を処置する方法 |
| US11406715B2 (en) | 2015-05-30 | 2022-08-09 | Genentech, Inc. | Methods of treating HER2-positive metastatic breast cancer |
| WO2017087280A1 (en) | 2015-11-16 | 2017-05-26 | Genentech, Inc. | Methods of treating her2-positive cancer |
| AU2017387909A1 (en) | 2016-12-28 | 2019-06-27 | Genentech, Inc. | Treatment of advanced HER2 expressing cancer |
| SG11201905622VA (en) | 2017-01-17 | 2019-08-27 | Genentech Inc | Subcutaneous her2 antibody formulations |
| US11077189B2 (en) | 2017-03-02 | 2021-08-03 | Genentech Inc. | Adjuvant treatment of HER2-positive breast cancer |
| EP3615695A1 (en) | 2017-04-24 | 2020-03-04 | Genentech, Inc. | Erbb2/her2 mutations in the transmebrane or juxtamembrane domain |
| AU2020456731A1 (en) | 2020-06-29 | 2023-01-05 | F. Hoffmann-La Roche Ag | Pertuzumab plus trastuzumab fixed dose combination |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO1993021319A1 (en) | 1992-04-08 | 1993-10-28 | Cetus Oncology Corporation | HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES |
| CN101412758A (zh) | 1996-10-18 | 2009-04-22 | 基因技术股份有限公司 | 抗ErbB2抗体 |
| US7718387B2 (en) * | 2001-09-20 | 2010-05-18 | Board Of Regents, The University Of Texas System | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| ES2392525T3 (es) * | 2002-07-15 | 2012-12-11 | F. Hoffmann-La Roche Ag | Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4 |
-
2006
- 2006-06-29 MY MYPI20063118A patent/MY157955A/en unknown
- 2006-06-29 US US11/477,772 patent/US20070009976A1/en not_active Abandoned
- 2006-07-04 TW TW095124248A patent/TWI312864B/zh active
- 2006-07-04 AR ARP060102872A patent/AR053948A1/es not_active Application Discontinuation
- 2006-07-05 CA CA002613187A patent/CA2613187A1/en not_active Abandoned
- 2006-07-05 EP EP06754671A patent/EP1902315A1/en not_active Withdrawn
- 2006-07-05 RU RU2008103608/15A patent/RU2008103608A/ru unknown
- 2006-07-05 NZ NZ564471A patent/NZ564471A/en unknown
- 2006-07-05 EP EP10157725A patent/EP2194380A3/en not_active Withdrawn
- 2006-07-05 WO PCT/EP2006/006524 patent/WO2007003420A1/en not_active Ceased
- 2006-07-05 KR KR1020087000259A patent/KR20080016939A/ko not_active Ceased
- 2006-07-05 JP JP2008519853A patent/JP2008545145A/ja active Pending
- 2006-07-05 AU AU2006265275A patent/AU2006265275A1/en not_active Abandoned
- 2006-07-05 BR BRPI0612591-3A patent/BRPI0612591A2/pt not_active IP Right Cessation
- 2006-07-05 MX MX2008000277A patent/MX2008000277A/es not_active Application Discontinuation
-
2007
- 2007-12-20 IL IL188317A patent/IL188317A0/en unknown
- 2007-12-21 CR CR9635A patent/CR9635A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076662A patent/NO20076662L/no not_active Application Discontinuation
-
2008
- 2008-01-04 EC EC2008008081A patent/ECSP088081A/es unknown
- 2008-02-01 MA MA30617A patent/MA29730B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1902315A1 (en) | 2008-03-26 |
| AU2006265275A1 (en) | 2007-01-11 |
| TWI312864B (en) | 2009-08-01 |
| WO2007003420A1 (en) | 2007-01-11 |
| ECSP088081A (es) | 2008-02-20 |
| MA29730B1 (fr) | 2008-09-01 |
| EP2194380A3 (en) | 2010-07-14 |
| CA2613187A1 (en) | 2007-01-11 |
| IL188317A0 (en) | 2008-04-13 |
| KR20080016939A (ko) | 2008-02-22 |
| AR053948A1 (es) | 2007-05-23 |
| EP2194380A2 (en) | 2010-06-09 |
| TW200741203A (en) | 2007-11-01 |
| NZ564471A (en) | 2010-04-30 |
| MY157955A (en) | 2016-08-30 |
| US20070009976A1 (en) | 2007-01-11 |
| MX2008000277A (es) | 2008-03-24 |
| RU2008103608A (ru) | 2009-08-20 |
| NO20076662L (no) | 2008-04-03 |
| BRPI0612591A2 (pt) | 2010-11-23 |
| JP2008545145A (ja) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR9635A (es) | Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente | |
| WO2020047010A3 (en) | Increasing spatial array resolution | |
| EP4567127A3 (en) | Methods for determining a location of a biological analyte in a biological sample | |
| EP4273551A3 (en) | Multiplexed total antibody and antibody-conjugated drug quantification assay | |
| ES2528321T3 (es) | Detección de a-fucosilación en anticuerpos | |
| EP4249605A3 (en) | Methods for analyte detection | |
| CO2019002607A2 (es) | Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto | |
| MX363201B (es) | Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico. | |
| ES2530734T3 (es) | Biomarcador en suero bioquímico | |
| MX358772B (es) | Metodo para detectar cancer. | |
| BR112016009460A8 (pt) | método para detectar a presença de anticorpos neutralizantes, e, kit | |
| BR122019018448B8 (pt) | método para extração de succinilacetona e um ou mais analitos biológicos adicionais | |
| CO2019002608A2 (es) | Biomarcadores de arn para angioedema hereditario | |
| CR20110530A (es) | Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas | |
| TW200801202A (en) | Alpha-enolase specific antibody and method of use | |
| BR112018007842A2 (pt) | imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk) | |
| PE20220004A1 (es) | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh | |
| BR112014031958A2 (pt) | bag3 como marcador de tecido e soro bioquímico | |
| EA201692071A1 (ru) | Иммуноанализ и антитела для обнаружения хромогранина а | |
| EA201400571A1 (ru) | Специфичные к трансресвератролу антитела и их применение | |
| PE20130526A1 (es) | Componentes de la pared de celulas de levadura y deteccion de los mismos | |
| AR108771A1 (es) | MÉTODO PARA LA DETECCIÓN DE UN ANTICUERPO IgM ESPECÍFICO PARA UN FLAVIVIRUS EN UNA MUESTRA | |
| WO2010053772A3 (en) | Disease-associated antigens and methods of use thereof | |
| RU2014110231A (ru) | Мембранный белок микровезикул и его применение | |
| CO2019002599A2 (es) | Biomarcadores proteicos para enfermedades asociadas con el sistema de activación por contacto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |